Abstract: An apparatus for fabricating a display panel includes: a fixing frame for fixing an outer circumference of a transfer film on which a plurality of light-emitting elements is arranged; an optical inspection member including a light source for irradiating light toward the transfer film and a light-receiving sensor in an optical path of the light source; and an elongation processing member for elongating a width of the transfer film toward an outer circumference thereof and for controlling a degree of elongation based on detection results by the optical inspection member. The light-emitting elements include first light-emitting elements and second light-emitting elements, and the second light-emitting elements include alignment keys on one side.

Abstract: The present disclosure retates to a method and device for prediction with a machine learning-based hybrid model. The prediction method includes: creating a first model for predicting a demand pattern for a combination of product features through K-means and ANN based on historical data; creating a second model for predicting a total demand for a period to be predicted using QRNN; predicting the demand pattern in the first model and the total demand in the second model by using features of the new product as input variables in the first model and the second model; creating a third model for calculating a specific demand for each time slot by reflecting the total demand predicted through the second model in the demand pattern calculated through the first model; and predicting a result using the third model.

Abstract: An organic electric element includes a hole transport band layer which includes compound represented by Formula 1 and an electron transport band layer includes compound represented by Formula 2. The driving voltage of an organic electric element including the organic electric element can be lowered and the luminous efficiency and lifespan can be improved.

Abstract: The present invention relates to a halophilic Bacillus polyfermenticus KMU01 strain producing salt-tolerant gamma-glutamyl transpeptidase, and the halophilic Bacillus polyfermenticus KMU01 strain according to the present invention (KCTC11751BP) producing a halophilic gamma-glutamyl transpeptidase, wherein, when food is fermented using the strain of the present invention, it can be utilized in foods with high salt concentration, and fermented foods having excellent flavor and various peptides can be prepared by high enzyme activity that decomposes protein binding.

Abstract: Embodiments of the inventive concept provide a wireless power apparatus for a substrate treating apparatus and a manufacturing method for the wireless power apparatus for the substrate treating apparatus for preventing a heat generation by preventing a generation of an eddy current in a coupling element, if the coupling element is used around an outer housing at which an induced magnetic field is formed. The inventive concept provides a wireless power apparatus for a substrate treating apparatus.

Abstract: A semiconductor device including a first interlayer insulating film; a conductive pattern in the first interlayer insulating film; a resistance pattern on the conductive pattern; an upper etching stopper film spaced apart from the resistance pattern, extending in parallel with a top surface of the resistance pattern, and including a first metal; a lower etching stopper film on the conductive pattern, extending in parallel with a top surface of the first interlayer insulating film, and including a second metal; and a second interlayer insulating film on the upper etching stopper film and the lower etching stopper film, wherein a distance from a top surface of the second interlayer insulating film to a top surface of the upper etching stopper film is smaller than a distance from the top surface of the second interlayer insulating film to a top surface of the lower etching stopper film.

Abstract: The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.

Abstract: The present invention relates to a pharmaceutical composition, a pharmaceutical combined formulation, and a combined formulation kit, each comprising, as active ingredients, an oral antiviral agent and a therapeutic vaccine including a lipopeptide and a poly(I:C) adjuvant. When the pharmaceutical composition, the pharmaceutical combined agent, and the combined formulation kit are administered/used in hepatitis B patients, a remarkable synergy occurs in terms of therapeutic index for chronic hepatitis B, compared to patients who have undergone standard therapy including the administration of conventional antiviral agents, exhibiting the possibility of completely curing the disease.

Abstract: Disclosed is a quantum key distribution system using an RFI (reference frame independent) QKD (quantum key distribution) protocol, which includes a first signal processing circuit that generates transmission basis information and transmission bit information, a quantum channel transmitter that generates a single photon or coherent light, and modulates the single photon or the coherent light based on the transmission basis information and the transmission bit information to generate a quantum signal, a quantum channel receiver that receives the quantum signal through a quantum channel and detects reception bit information from the quantum signal based on reception basis information, and a second signal processing circuit that generates the reception basis information, transmits the reception basis information to the first signal processing circuit through a public channel, and receives the transmission basis information from the first signal processing circuit through the public channel.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: The present invention relates to a recombinant herpes zoster vaccine comprising liposome and lipopeptide and a method for preparing the same. More particularly, a vaccine composition according to the present invention, prepared using Lipo-Pam, which is a composite adjuvant comprising a liposome and various kinds of lipopeptides, and a varicella-zoster virus gE antigen, a Japanese encephalitis virus gE antigen, or a seasonal inactivated influenza virus antigen, highly induces a cell-mediated immune response as well as a humoral immune response so that the composition of the present invention can be commercially useful.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: An automatic scroll control method for synchronizing positions of an original text and a translation includes displaying, by a processor of a terminal device, the original text on a first display and displaying the translation corresponding to the original text on a second display; and when the original text or the translation is scrolled by a drag operation of a user, synchronizing the display positions of the original text and the translation with each other.

Abstract: A method that detects adverse drug reactions based on machine learning is provided. The method includes receiving raw data including information on adverse events of a plurality of patients with respect to a target drug; classifying the raw data into first data corresponding to adverse reactions of the target drug, second data corresponding to no adverse reactions of the target drug and drugs similar to the target drug, and third data by implementing a database including information about adverse reactions of the target drug and drugs similar to the target drug based on a predetermined standard; learning a machine learning model by implementing a gold standard dataset including data corresponding to the first data and the second data; and determining a possibility of adverse reactions for the prediction dataset including the data corresponding to the third data by implementing the machine learning model.

Abstract: Disclosed is a quantum key distribution system using an RFI (reference frame independent) QKD (quantum key distribution) protocol, which includes a first signal processing circuit that generates transmission basis information and transmission bit information, a quantum channel transmitter that generates a single photon or coherent light, and modulates the single photon or the coherent light based on the transmission basis information and the transmission bit information to generate a quantum signal, a quantum channel receiver that receives the quantum signal through a quantum channel and detects reception bit information from the quantum signal based on reception basis information, and a second signal processing circuit that generates the reception basis information, transmits the reception basis information to the first signal processing circuit through a public channel, and receives the transmission basis information from the first signal processing circuit through the public channel.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: A semiconductor device package includes a semiconductor chip mounted to an upper surface of a package substrate by a package ball. The package substrate includes a ball pad on the upper surface of the package substrate and connected to the package ball, a signal trace located below the upper surface of the package substrate, and an impedance matching element connected between the ball pad and the signal trace. The impedance matching element is configured to establish impedance matching with a termination impedance of the semiconductor chip.

Abstract: An automatic scroll control method for synchronizing positions of an original text and a translation includes displaying, by a processor of a terminal device, the original text on a first display and displaying the translation corresponding to the original text on a second display; and when the original text or the translation is scrolled by a drag operation of a user, synchronizing the display positions of the original text and the translation with each other.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: A method for displaying a web browser of a terminal device having a first display area and a second display area includes displaying web contents in the first display area by executing the web browser; receiving an enlargement request for the web contents from a user; and enlarging and displaying the web contents in the second display area in response to the enlargement request.